Announced Mon, 20 Jul · 15:28 IST
Vimta Labs Q1 FY27: Revenue up 13.7% YoY at Rs 1,129 Mn
Compliance View source PDF
VIMTALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.9%1-day move
₹558.00
prior close
₹527.85
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+7.9+4.4+1.6+1.8+5.6—————
Up moveDown movePending
AI summary
Vimta Labs reported Q1 FY27 results with total income at Rs 1,129 Mn, up 13.7% YoY from Rs 993 Mn. EBITDA rose 16% YoY to Rs 411 Mn with 36.4% margin. PAT grew 11.4% YoY to Rs 210 Mn (margin 18.6%); EPS at Rs 4.7. Sequentially, growth was flat compared to Q4 FY26. Pharma research and testing services saw strong traction, while food testing faced global headwinds. The company commenced Biologics CRADS operations and completed a Ukraine regulatory audit.
Likely market impact
Strong YoY growth in revenue and profits with margin expansion; flat sequential performance and food testing headwinds are near-term watchpoints.